Intellipharmaceutics International Inc. IPCIF
Set alert
0.15 0.00 0.00%
As of Nov 25, 3:00 PM ET
0.15 Day range 0.15
52-week range unavailable
- Open
- 0.00
- Prev close
- 0.15
- Mkt cap
- 4.96M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
More statistics
- Low
- 0.15
- High
- 0.15
- Earnings
- Nov 18, 2024
Next earnings
Nov 18, 2024
Expected Nov 18, 2024. Consensus EPS estimate 0.00.
Financials — quick view
IPCIF Revenue — quarterly 29.68K
IPCIF Net income — quarterly -874.73K
IPCIF EPS — quarterly -0.02
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 18, 2024 | Aug 1, 2024 | 0.00 | — | — | — |
| Sep 6, 2024 | May 1, 2024 | 0.00 | — | — | — |
| Oct 16, 2023 | Aug 1, 2023 | 0.00 | — | — | — |
| Jul 14, 2023 | May 1, 2023 | 0.00 | — | — | — |
| Jun 6, 2023 | Feb 1, 2023 | 0.00 | — | — | — |
News
- Analyzing Nuvo Pharmaceuticals (OTCMKTS:MRVFF) and Intellipharmaceutics International (OTCMKTS:IPCIF)
- Reviewing Intellipharmaceutics International (OTCMKTS:IPCIF) & Neoleukin Therapeutics (NASDAQ:NLTX)
- Intellipharmaceutics Announces Downgrade to OTC Expert Market
- Intellipharmaceutics International Inc. Announces Transfer of Listing to NEX and New Stock Option Plan
- Intellipharmaceutics Announces Cease Trade Order
- Intellipharmaceutics Announces Its Expected Delay in Filing Annual Audited Financial Statements and Annual Information Form
- Intellipharmaceutics International Inc. Announces Stock Option Grant
- Intellipharmaceutics International Inc. Receives Conditional Approval to List on the TSX Venture Exchange
- Intellipharmaceutics Announces Third Quarter 2023 Results
- Intellipharmaceutics Reports Director Election Results
Your note
Sign in to keep a note on IPCIF — it syncs with the Stock Master app.